Abstract

Case Report

Regeneration of deep intrabony periodontal defects with enamel matrix derivative: A case report

Lopes Otão P* and Mascarenhas P

Published: 19 March, 2021 | Volume 6 - Issue 1 | Pages: 001-005

A clinical case of treatment of two severe intrabony defects on the aesthetic zone is reported and followed for one year.

The biomaterial of choice was enamel matrix derivative (Emdogain®; Straumann™) alone with a preservation papilla flap and a minimally invasive surgical technique.

After surgical treatment, the patient was kept in a supportive periodontal therapy programme with 6-month interval between appointments.

In the one year after surgery appointment, clinical and radiographic changes were observed, showing periodontal health and stability. 

Read Full Article HTML DOI: 10.29328/journal.johcs.1001033 Cite this Article Read Full Article PDF

Keywords:

Premaxilla osteotomy; Bilateral cleft lip and palate; Cephalometric analysis

References

  1. Lang NP. Focus on intrabony defects - Conservative therapy. Periodontol. 2000; 22: 51–58. PubMed: https://pubmed.ncbi.nlm.nih.gov/11276516/
  2. Papapanou PN, Wennström JL. The angular bony defect as indicator of further alveolar bone loss. J Clin Periodontol. 1991; 18: 317–322. PubMed: https://pubmed.ncbi.nlm.nih.gov/2066446/
  3. Cortellini P, Stalpers G, Mollo A, Tonetti MS. Periodontal regeneration versus extraction and prosthetic replacement of teeth severely compromised by attachment loss to the apex: 5-year results of an ongoing randomized clinical trial. J Clin Periodontol. 2011; 38: 915–924. PubMed: https://pubmed.ncbi.nlm.nih.gov/21777268/
  4. Cortellini P, Tonetti MS. Clinical concepts for regenerative therapy in intrabony defects. Periodontol 2000. 2015; 68: 282–307. PubMed: https://pubmed.ncbi.nlm.nih.gov/25867990/
  5. Pretzl B, Kim TS, Holle R, Eickholz P. Long-Term Results of Guided Tissue Regeneration Therapy With Non-Resorbable and Bioabsorbable Barriers. IV. A Case Series of Infrabony Defects After 10 Years. J Periodontol. 2008; 79: 1491–1499. PubMed: https://pubmed.ncbi.nlm.nih.gov/18673000/
  6. Eickholz P, Krigar D-M, Pretzl B, Steinbrenner H, Dörfer C, Kim TS. Guided Tissue Regeneration With Bioabsorbable Barriers. II. Long-Term Results in Infrabony Defects. J Periodontol. 2004; 75: 957–965. PubMed: https://pubmed.ncbi.nlm.nih.gov/15341353/
  7. Pini Prato G, Cortellini P. Thirty-year stability after regeneration of a deep intrabony defect: a case report. J Clin Periodontol. 2016; 43: 857–862. PubMed: https://pubmed.ncbi.nlm.nih.gov/27279353/
  8. Nibali L, Koidou VP, Nieri M, Barbato L, Pagliaro U, et al. Regenerative surgery versus access flap for the treatment of intra-bony periodontal defects: A systematic review and meta-analysis. J Clin Periodontol. 2020; 47: 320–351. PubMed: https://pubmed.ncbi.nlm.nih.gov/31860134/
  9. Miron RJ, Sculean A, Cochran DL, Froum S, Zucchelli G, et al. Twenty years of enamel matrix derivative: the past, the present and the future. J Clin Periodontol. 2016; 43: 668-683. PubMed: https://pubmed.ncbi.nlm.nih.gov/26987551/
  10. Cortellini P, Buti J, Pini Prato G, Tonetti MS. Periodontal regeneration compared with access flap surgery in human intra-bony defects 20-year follow-up of a randomized clinical trial: tooth retention, periodontitis recurrence and costs. J Clin Periodontol. 2017; 44: 58–66. PubMed: https://pubmed.ncbi.nlm.nih.gov/27736011/
  11. Sanz M, Jepsen K, Eickholz P, Jepsen S. Clinical concepts for regenerative therapy in furcations. Periodontol 2000. 2015; 68: 308–332. PubMed: https://pubmed.ncbi.nlm.nih.gov/25867991/
  12. Textbook of Periodontia. Philadelphia: Blakiston; 1950; 900.
  13. Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, et al. A new classification scheme for periodontal and peri-implant diseases and conditions – Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018; 45: S1–8. PubMed: https://pubmed.ncbi.nlm.nih.gov/29926489/
  14. Cortellini P, Tonetti MS. Minimally invasive surgical technique and enamel matrix derivative in intra-bony defects. I: Clinical outcomes and morbidity. J Clin Periodontol. 2007; 34: 1082-1088. PubMed: https://pubmed.ncbi.nlm.nih.gov/17953696/
  15. Cortellini P, Prato GP, Tonetti MS. The simplified papilla preservation flap. A novel surgical approach for the management of soft tissues in regenerative procedures. Int J Periodontics Restorative Dent. 1999; 19: 589-599. PubMed: https://pubmed.ncbi.nlm.nih.gov/10815597/
  16. Lang NP, Bartold PM. Periodontal health. J Clin Periodontol. 2018; 45: S9–16. PubMed: https://pubmed.ncbi.nlm.nih.gov/29926938/
  17. Sculean A, Donos N, Chiantella GC, Windisch P, Reich E, Brecx M. GTR with Bioresorbable Membranes in the Treatment of Intrabony Defects: A Clinical and Histologic Study. Int J Periodontics Restorative Dent. 1999; 19: 501–509. PubMed: https://pubmed.ncbi.nlm.nih.gov/10709516/
  18. Cardaropoli G, Leonhardt ÅS. Enamel Matrix Proteins in the Treatment of Deep Intrabony Defects. J Periodontol. 2002; 73: 501-504. PubMed: https://pubmed.ncbi.nlm.nih.gov/12027251/
  19. Evaluation of Enamel Matrix Derivative as an Adjunct to Minimally Invasive Non-surgical Treatment of Intrabony Defects. 2018. https://clinicaltrials.gov/show/NCT03622255
  20. Trombelli L, Bottega S, Zucchelli G. Supracrestal soft tissue preservation with enamel matrix proteins in treatment of deep intrabony defects: A report of 35 consecutively treated cases. J Clin Periodontol. 2002; 29: 433-439. PubMed: https://pubmed.ncbi.nlm.nih.gov/12060426/
  21. Trombelli L, Bottega S, Zucchelli G. Supracrestal soft tissue preservation with enamel matrix proteins in treatment of deep intrabony defects. J Clin Periodontol. 2002; 29:433-439. PubMed: https://pubmed.ncbi.nlm.nih.gov/12060426/
  22. Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington H V. Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev. 2009; 2: 247-266. PubMed: https://pubmed.ncbi.nlm.nih.gov/20467602/
  23. Sanz M, Herrera D, Kebschull M, Chapple I, Jepsen S, Beglundh T, et al. Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline. J Clin Periodontol. 2020; 47: 4–60. PubMed: https://pubmed.ncbi.nlm.nih.gov/32383274/
  24. Sculean A, Schwarz F, Becker J, Brecx M. The application of an enamel matrix protein derivative (Emdogain®) in regenerative periodontal therapy: A review. Med Principles Practice. 2007; 16: 167-180. PubMed: https://pubmed.ncbi.nlm.nih.gov/17409750/
  25. Sculean A, Berakdar M, Donos N, Auschill TM, Arweiler NB. The effect of postsurgical administration of a selective cyclo-oxygenase-2 inhibitor on the healing of intrabony defects following treatment with enamel matrix proteins. Clin Oral Investig. 2003; 7: 108-112. PubMed: https://pubmed.ncbi.nlm.nih.gov/12720115/

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Figure 1

Figure 5

Figure 1

Figure 6

Figure 1

Figure 7

Figure 1

Figure 8

Figure 1

Figure 9

Figure 1

Figure 10

Figure 1

Figure 11

Figure 1

Figure 12

Figure 1

Figure 13

Figure 1

Figure 14

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More